Participated · Series B · Jan 2026

enechain provides eSquare Live, an online marketplace where market participants can buy and sell electricity, fuels, and environmental value products. The platform has handled more than ¥3 trn in cumulative wholesale electricity transactions, and its screen‐based trading volume via eSquare Live grew more than 25× year-on-year. To reduce counterparty and settlement risk, the company runs joint ventures eClear (with MUFG Bank) for power-trade clearing and eXstend (with Sumitomo Mitsui Financial Group) for fuel-price hedging. Following its latest financing, enechain’s paid-in capital has reached roughly ¥10 bn and group-wide funding now totals several hundred billion yen. The new capital will be used to upgrade eSquare Live to global-class UX and reliability standards, aggregate additional products and data, deepen ecosystem integrations, and embed advanced AI capabilities through a newly created AI lab. The company will also invest heavily in cybersecurity and consider M&A to accelerate energy-sector digital transformation.

Led · Series D · Feb 2025

Eikon Therapeutics integrates advanced engineering, single-molecule tracking and high-performance computing to visualize protein movement in living cells and accelerate drug discovery. Its clinical portfolio is anchored by EIK1001, a systemically administered TLR7/8 co-agonist now in Phase III for advanced melanoma, alongside EIK1003 (a PARP1 inhibitor in Phase 1) and EIK1004 (a CNS-penetrant PARP1-selective inhibitor poised to enter Phase 1 for brain cancers). The company is also advancing earlier-stage candidates, including two androgen receptor antagonists and an internally derived WRN inhibitor (EIK1005) for MSI-high and other DNA repair–deficient cancers. Clinical studies are operating in 28 countries across five continents, and Eikon says it is expanding R&D and building a fully integrated, 21st-century biotechnology company. Financially, Eikon announced the initial closing of a $350.7 million Series D and has privately raised in excess of $1.1 billion since its 2019 founding. Eikon operates facilities in California, New Jersey, and New York. Eikon Therapeutics integrates engineering and science to discover and advance drug candidates using its proprietary AI-powered Single Molecule Tracking (SMT) technology. The company’s internally developed programs focus on preclinical candidates in oncology, immunology, and neurologic disease. Eikon has expanded its pipeline by acquiring global rights to clinical-stage TLR7/8 agonists, licensing PARP1-selective inhibitors, and acquiring preclinical assets addressing protein homeostasis, DNA damage repair, and chromatin remodeling. Its clinical team has deep experience in advancing programs through regulatory review, and Eikon intends to use its SMT instruments to inform clinical-trial design and program decisions. Financially, Eikon completed a first close of a Series C equity financing that added nearly $106 million and has raised nearly $775 million in total capital since its founding in late 2019. Eikon Therapeutics builds a drug-discovery platform centered on super-resolution fluorescence microscopy, single-particle tracking and the quantitative data those microscopes generate. The company is focused on industrializing that platform to run high-throughput, live-cell drug screens and to reveal new biology and drug targets. Eikon is pursuing four unnamed target programs and has one undisclosed partner. Leadership and scale-up are priorities: the company plans to grow its roughly 100-person team (with an aim to double headcount) and has made multiple senior hires while operating under the oversight of Roger Perlmutter. Management says the platform is already running drug screens around the clock and generating high volumes of quantitative protein-dynamics data. Financially, Eikon has raised a large Series B and has accumulated over $668 million in total disclosed financing. Eikon Therapeutics has developed a live-cell super-resolution microscopy platform that measures the real-time movement of individual proteins in living cells to inform drug discovery. The platform evolved from Nobel Prize–winning work in super-resolution microscopy by Eric Betzig and collaborators and was industrialized by founders Betzig, Xavier Darzacq, Luke Lavis, and Robert Tjian. Eikon combines physics, engineering, chemistry, biology, automation, machine learning, and high-performance computing to apply protein-dynamics measurements across the drug discovery process. The company aims to translate these biological insights into differentiated therapeutics for unmet medical needs. Eikon is based in Hayward, Calif., and recently closed a $148 million Series A financing. The company also announced the appointment of Roger M. Perlmutter as its Chief Executive Officer and maintains a multidisciplinary scientific advisory board and leadership team to advance its platform.

Participated · Series D · Jan 2024

Tabby started as a BNPL pioneer in the Middle East and has broadened into online and in‑store payments and wider financial services. Its core products include online/in‑store BNPL, the Tabby Card for flexible spending, Tabby Plus subscription rewards, and Tabby Shop for longer‑term payment plans. The company says it is profitable, serves 15 million customers, and supports more than 40,000 brands and merchants. Tabby reports annualized transaction volume has doubled to over $10 billion, and management attributes improved profitability to new product launches that increased usage frequency. The fintech has expanded via acquisitions such as Tweeq, a Saudi digital wallet provider, and is building digital accounts, payments, money‑management tools and remittance offerings. It serves major merchants including Amazon, Adidas, IKEA, Samsung, and Noon and is positioning itself to scale into a broader financial ecosystem. Tabby operates a buy now, pay later platform and is described as the top financial services and shopping app in the Middle East and North Africa. The company securitized up to $700 million in receivables via a J.P. Morgan-led pre-IPO asset-backed debt facility, the largest such fintech deal in the region. It also concurrently extended its Series D financing to close $250 million with participation from Hassana Investment Company, Saudi Venture Capital (SVC), and Soros Capital Management. The financings strengthen Tabby’s balance sheet and provide additional capital to support expansion of its financial services and shopping products. Tabby serves roughly 10 million customers and 30,000 retailers and will use the proceeds to amplify reach, market penetration, and product innovation. Company leadership framed the securitization as a regional milestone reflecting rapid growth in the fintech landscape. Tabby provides BNPL checkout and in‑store payment services across Saudi Arabia, the UAE and Kuwait, working with more than 30,000 brands and serving over 10 million users. The company claims profitability and reports a threefold revenue growth, with an annualized transaction volume of over $6 billion. Tabby has expanded product offerings including Tabby Cards (adopted in over 4,000 stores) and Tabby Shop, which showcases over 500,000 products. Management moved the headquarters from Dubai to Riyadh and is preparing for a potential IPO on the Saudi exchange. The startup says it will invest further in its core markets and roll out additional credit and financial‑services products such as payments and savings. Tabby is a shopping and financial services app in the MENA region offering buy-now-pay-later and related consumer finance products. Its core product is a BNPL service integrated across online and offline retail, supported by the Tabby app and Tabby Card. The company reports over 4 million active customers, more than 20,000 daily installs, over 5 million monthly store visits, and over 280,000 Tabby Cards issued in the UAE. Tabby partners with over 15,000 businesses, including major retailers such as H&M, Adidas, IKEA, SHEIN, noon, and Bloomingdale’s. It is active in Saudi Arabia, the UAE and Kuwait and says it is valued at $660 million in its latest equity round. The additional financing will support its core BNPL business and enable serving more customers, retailers, and purchases. Tabby operates a BNPL platform that lets users make flexible, cost-free installment payments both online and in-store with global and regional retailers. The company has expanded beyond Saudi Arabia, the UAE and Kuwait to include operations in Egypt and recently launched a cards program. Tabby says more than 3 million users now shop with the service across 10,000+ brands, and it has issued over 150,000 Tabby Cards with in-store sales representing more than 10% of volumes. Revenues have increased fivefold over the past year. The company plans to expand its product line into a broader set of consumer financial services and has begun offering a product for everyday purchases that lets customers without credit cards pay at the end of the month. Tabby has raised capital and is positioning to deepen engagement as customers transact more frequently.

Led · Series A · Nov 2022

Pickle Robot Company develops tethered systems that teach off-the-shelf robot arms how to pick up boxes and “play Tetris” to automate truck and pallet unloading. The team is founded by a cast of MIT alumni and is led by CEO AJ Meyer. Pickle has run pilots with United Exchange Corporation and says it has unloaded tens-of-thousands of packages per month at customer sites, primarily in Southern California. The company positions its product as a focused solution to the challenging and repetitive work of unloading trucks and pallets. Pickle faces competition from other robotics players such as Boston Dynamics’ Stretch and Agility’s exploration of Digit for unloading, but sees a large addressable market. Management says the new funding will help accelerate customer acquisition and build the infrastructure to deliver more systems to more customers. Pickle Robot Company develops low-cost, collaborative package-handling robots that automate sorting, loading and unloading tasks in distribution and fulfillment centers. Its robots are designed to retrofit inexpensively into existing operations and increase the processing rate of the entire packaging facility. The company was founded by an MIT alumni group of robotics and machine-learning experts and focuses on systems that work alongside people at loading docks. Pickle’s stated mission is to move packages seamlessly in and out of distribution and fulfillment centers and to reduce the arduous human effort involved in order fulfillment. The company is based in Cambridge, Mass., and intends to scale its solutions through strategic partnerships and deployment across high-volume logistics operations. Pickle is an MIT spinoff that builds a collaborative package-picking robot named "Dill" focused on trailer unloading and loading-dock automation. The company says Dill can perform 1,600 picks per hour from the back of a trailer, which it claims is double the speed of competitors. Pickle emphasizes human-robot collaboration, designing people into the system rather than pursuing fully unsupervised solutions, and has deployed robots in real warehouses. Orders for the first product targeted at trailer unloading open in June, with an expected ship date in early 2022. The company launched with limited funding and a small team and recently closed a seed financing to support commercialization and scale production.

Participated · Series B · Oct 2021

Creapaper produces an alternative raw material for paper and packaging made primarily from dried grass (hay) and processes it into grass-fibre pellets that can replace wood or waste-paper pulp. The company says its grass-paper production emits up to 75% less CO2 and requires about two liters of water to produce one ton of paper versus roughly 6,000 liters for conventional wood- or recycled-paper processes. Creapaper has developed CO2-saving products including hygienic papers, food and carrying bags, and single-use plastic replacements, which it has placed with retail clients in Germany, Switzerland, Austria, the Netherlands, and Italy. Founded in 2012, the company emphasizes reducing energy, water and chemical consumption in the paper industry and uses a patented process to make pellets from grass fibre. It has hired industry executive Jeannette Thull to promote strategic product ranges and prepare for national and international key accounts. Financially, Creapaper recently closed a €20M Series B and previously received €1.7M in funding from the European Innovation Council in December 2020. Creapaper uses a patented process to produce grasspaper, an alternative raw material for the paper and packaging industry that can replace wood‑based cellulose pulp and waste paper. Its grasspaper products include hygienic papers, food and carrying bags and single‑use plastic replacements. The company highlights significant CO2 and water savings from its materials and has placed products with retail clients in Germany, Switzerland, Austria, the Netherlands and Italy. Creapaper has received multiple awards and EU program support, including the IKU Innovation Award Climate and Environment 2018, the Red Herring Award North America 2019, EU Horizon 2020 recognition, and selection for the EIC Accelerator. The company is expanding its reach across Europe and positioning its grasspaper offerings for broader market adoption. Financially, Creapaper recently completed a financing round B that brought new investors and a strategic partnership with Ranpak. Creapaper produces a grassfibre-based raw material and a range of grasspaper products intended to substitute single-use plastics such as straws, cups, and bags. The grasspaper products reportedly save tons of carbon emissions, are free of noxious substances, printable, and have a distinctive sustainable yet premium appearance, making them attractive for packaging, single-use replacements, and tissue products. Several packaging-industry awards and first orders from large, well-known brands are cited as validation of the company's product USPs. Creapaper won a €1.7-million EIC Accelerator grant that the company says will significantly accelerate roll-out of its grasspaper products and enable it to meet logistical requirements of global brand owners. The company described the award as both important financial support and a motivational endorsement from EIC experts and the EIC Accelerator jury. The article highlights the competitiveness of the EIC Accelerator—4,223 companies applied in 2020 and only 38 were selected, including seven from Germany.